This article investigates the joint estimation and identification problem of discrete-time nonlinear systems with generalized unknown disturbances (GUDs) and unknown noise covariance (UNC) in the measurement model. A variational adaptive Gaussian approximation filter (VAGAF) is proposed, in which the Gaussian approximation filter performs recursive state estimation, while the variational Bayesian inference identifies the UNC. Since the existence of GUDs makes it difficult to accurately derive the innovation covariance, it is approximated through matrix eigenvalue decomposition. The measurement noise covariance is estimated online by applying statistical linear regression (SLR) to the nonlinear measurement model, enabling the implementation of variational Bayesian inference. Based on the identified measurement noise covariance and the constructed innovation covariance, the Gaussian approximation filter recursively achieves high-precision state estimation. Target-tracking simulations demonstrate that the proposed filter attains superior estimation accuracy compared with the minimum upper-bound filter and interacting multiple model method without requiring a finely designed model set.
{"title":"Variational adaptive Gaussian approximation filter for nonlinear systems with generalized unknown disturbances","authors":"Yuemei Qin , Jincheng Lv , Shuying Li , Yinlong Hou","doi":"10.1016/j.isci.2025.114331","DOIUrl":"10.1016/j.isci.2025.114331","url":null,"abstract":"<div><div>This article investigates the joint estimation and identification problem of discrete-time nonlinear systems with generalized unknown disturbances (GUDs) and unknown noise covariance (UNC) in the measurement model. A variational adaptive Gaussian approximation filter (VAGAF) is proposed, in which the Gaussian approximation filter performs recursive state estimation, while the variational Bayesian inference identifies the UNC. Since the existence of GUDs makes it difficult to accurately derive the innovation covariance, it is approximated through matrix eigenvalue decomposition. The measurement noise covariance is estimated online by applying statistical linear regression (SLR) to the nonlinear measurement model, enabling the implementation of variational Bayesian inference. Based on the identified measurement noise covariance and the constructed innovation covariance, the Gaussian approximation filter recursively achieves high-precision state estimation. Target-tracking simulations demonstrate that the proposed filter attains superior estimation accuracy compared with the minimum upper-bound filter and interacting multiple model method without requiring a finely designed model set.</div></div>","PeriodicalId":342,"journal":{"name":"iScience","volume":"29 1","pages":"Article 114331"},"PeriodicalIF":4.1,"publicationDate":"2025-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145788917","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-04DOI: 10.1016/j.isci.2025.114335
Yinchen Chen , Zunli Dai , Xiaohong Wang , Qiujing Zhang , Haoming Chen , Shiyuan Zhong , Qingheng Lu , Lejiang Yu
This study examines seasonal ozone (O3) dynamics across China using a random forest model with partial dependence plots. Daily monitoring and ERA5 reanalysis data for 2015–2020, combined with CMIP6 projections to 2100, quantify the marginal effects of meteorology, socioeconomic factors, and O3 precursors on O3 changes. Warm-season O3 peaks mainly north of 30°N, especially in North China, with surface temperature, relative humidity, and 500–850 hPa winds as dominant drivers. Cold-season patterns differ, reflecting widespread stagnation and reduced solar radiation. Scenario analyses under SSP 1–2.6, SSP 2–4.5, SSP 3–7.0, and SSP 5–8.5 reveal regionally heterogeneous trajectories, with some factors consistently elevating O3 and others mitigating it depending on season and location. These results underscore the need for region-specific controls that integrate evolving climate and socioeconomic pathways and provide an evidence base for adaptive air-quality management and policy.
{"title":"Meteorological and socioeconomic impacts on ozone in China: Past and future analysis","authors":"Yinchen Chen , Zunli Dai , Xiaohong Wang , Qiujing Zhang , Haoming Chen , Shiyuan Zhong , Qingheng Lu , Lejiang Yu","doi":"10.1016/j.isci.2025.114335","DOIUrl":"10.1016/j.isci.2025.114335","url":null,"abstract":"<div><div>This study examines seasonal ozone (O<sub>3</sub>) dynamics across China using a random forest model with partial dependence plots. Daily monitoring and ERA5 reanalysis data for 2015–2020, combined with CMIP6 projections to 2100, quantify the marginal effects of meteorology, socioeconomic factors, and O<sub>3</sub> precursors on O<sub>3</sub> changes. Warm-season O<sub>3</sub> peaks mainly north of 30°N, especially in North China, with surface temperature, relative humidity, and 500–850 hPa winds as dominant drivers. Cold-season patterns differ, reflecting widespread stagnation and reduced solar radiation. Scenario analyses under SSP 1–2.6, SSP 2–4.5, SSP 3–7.0, and SSP 5–8.5 reveal regionally heterogeneous trajectories, with some factors consistently elevating O<sub>3</sub> and others mitigating it depending on season and location. These results underscore the need for region-specific controls that integrate evolving climate and socioeconomic pathways and provide an evidence base for adaptive air-quality management and policy.</div></div>","PeriodicalId":342,"journal":{"name":"iScience","volume":"29 1","pages":"Article 114335"},"PeriodicalIF":4.1,"publicationDate":"2025-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145788920","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-04DOI: 10.1016/j.isci.2025.114336
Kit-Leong Cheong , Te Pan , Suresh Veeraperumal , Franck Quero , Gowsika Jaikumar , Timo Kikas , Malairaj Sathuvan , Karsoon Tan , Saiyi Zhong , Udayakumar Veerabagu
Chronic wounds represent a major global health burden, while conventional dressings often fail to meet the complex requirements of chronic wound management, including infection control, moisture balance, and tissue regeneration. In this study, two multifunctional zwitterionic hydrogels—vinylpyridine carboxybetaine/sulfobetaine/silver nanowire/carboxymethyl cellulose (VCS/Ag/CMC) and acrylamide carboxybetaine/sulfobetaine/silver nanowire/carboxymethyl cellulose (ACS/Ag/CMC) – were synthesized. Structural analyses confirmed the successful incorporation of aromatic or aliphatic zwitterionic components and uniform distribution of silver nanowires within the CMC-based hydrogel networks. Both hydrogels exhibited favorable mechanical strength, high swelling capacity, controlled degradability, and sustained silver release, providing a balanced profile for chronic wound applications. In vitro studies demonstrated potent antibacterial and antioxidant activities, while in vivo experiments revealed accelerated wound closure, enhanced re-epithelialization, collagen deposition, and neovascularization. Moreover, the hydrogels promoted macrophage polarization toward the pro-healing M2 phenotype. Collectively, these findings highlight the promise of zwitterionic hydrogels as multifunctional platforms for chronic wound management and regenerative medicine.
{"title":"Multifunctional carboxymethyl cellulose-based hydrogels with zwitterionic and silver nanowire components for wound management","authors":"Kit-Leong Cheong , Te Pan , Suresh Veeraperumal , Franck Quero , Gowsika Jaikumar , Timo Kikas , Malairaj Sathuvan , Karsoon Tan , Saiyi Zhong , Udayakumar Veerabagu","doi":"10.1016/j.isci.2025.114336","DOIUrl":"10.1016/j.isci.2025.114336","url":null,"abstract":"<div><div>Chronic wounds represent a major global health burden, while conventional dressings often fail to meet the complex requirements of chronic wound management, including infection control, moisture balance, and tissue regeneration. In this study, two multifunctional zwitterionic hydrogels—vinylpyridine carboxybetaine/sulfobetaine/silver nanowire/carboxymethyl cellulose (VCS/Ag/CMC) and acrylamide carboxybetaine/sulfobetaine/silver nanowire/carboxymethyl cellulose (ACS/Ag/CMC) – were synthesized. Structural analyses confirmed the successful incorporation of aromatic or aliphatic zwitterionic components and uniform distribution of silver nanowires within the CMC-based hydrogel networks. Both hydrogels exhibited favorable mechanical strength, high swelling capacity, controlled degradability, and sustained silver release, providing a balanced profile for chronic wound applications. <em>In vitro</em> studies demonstrated potent antibacterial and antioxidant activities, while <em>in vivo</em> experiments revealed accelerated wound closure, enhanced re-epithelialization, collagen deposition, and neovascularization. Moreover, the hydrogels promoted macrophage polarization toward the pro-healing M2 phenotype. Collectively, these findings highlight the promise of zwitterionic hydrogels as multifunctional platforms for chronic wound management and regenerative medicine.</div></div>","PeriodicalId":342,"journal":{"name":"iScience","volume":"29 1","pages":"Article 114336"},"PeriodicalIF":4.1,"publicationDate":"2025-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145788832","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-04DOI: 10.1016/j.isci.2025.114329
Erwan Sallard , Daniel Pembaur , Matias Ciancaglini , Lucie Manov-Bouard , Denice Weklak , Firas Hamdan , Chun Kit Chan , Franziska Jönsson , Elise Chabot , Carmen Musielak , Elena Scurti , Sara Feola , Sebastian Schellhorn , Nissai Beaude , Katrin Schröer , Daipayan Sarkar , Georgia Koukou , Xiaoyan Wang , Natascha Schmidt , Wibke Bayer , Anja Ehrhardt
The adenoviral vector-based AstraZeneca and Janssen COVID-19 vaccines have been associated with rare cases of thrombosis, believed to be triggered, among other factors, by vector binding to the blood protein platelet factor 4 (PF4). To identify vectors with lower thrombosis risk, we screened 50 natural and hexon-modified adenoviruses (Ads). Unlike the applied COVID-19 vaccines and most tested vectors, Ad34 and Ad80, as well as Ad5 vectors with deleted or chemically shielded hexon hyper-variable region 1 (HVR1), did not bind to PF4. Furthermore, interactions with PF4 substantially modified Ad5 infectivity in various immortalized and primary cells, suggesting that PF4 may influence existing vector tropism. Finally, HVR1-deleted Ad5 and Ad34 vectors expressing SARS-CoV-2 spike S1 domain were tested as vaccine candidates in mice and induced robust cellular immune responses. Therefore, the identified PF4 non-binding vectors may represent safe and efficient candidates for clinical applications.
{"title":"Novel adenovirus vaccine vectors lacking thrombosis-associated interactions with platelet factor 4","authors":"Erwan Sallard , Daniel Pembaur , Matias Ciancaglini , Lucie Manov-Bouard , Denice Weklak , Firas Hamdan , Chun Kit Chan , Franziska Jönsson , Elise Chabot , Carmen Musielak , Elena Scurti , Sara Feola , Sebastian Schellhorn , Nissai Beaude , Katrin Schröer , Daipayan Sarkar , Georgia Koukou , Xiaoyan Wang , Natascha Schmidt , Wibke Bayer , Anja Ehrhardt","doi":"10.1016/j.isci.2025.114329","DOIUrl":"10.1016/j.isci.2025.114329","url":null,"abstract":"<div><div>The adenoviral vector-based AstraZeneca and Janssen COVID-19 vaccines have been associated with rare cases of thrombosis, believed to be triggered, among other factors, by vector binding to the blood protein platelet factor 4 (PF4). To identify vectors with lower thrombosis risk, we screened 50 natural and hexon-modified adenoviruses (Ads). Unlike the applied COVID-19 vaccines and most tested vectors, Ad34 and Ad80, as well as Ad5 vectors with deleted or chemically shielded hexon hyper-variable region 1 (HVR1), did not bind to PF4. Furthermore, interactions with PF4 substantially modified Ad5 infectivity in various immortalized and primary cells, suggesting that PF4 may influence existing vector tropism. Finally, HVR1-deleted Ad5 and Ad34 vectors expressing SARS-CoV-2 spike S1 domain were tested as vaccine candidates in mice and induced robust cellular immune responses. Therefore, the identified PF4 non-binding vectors may represent safe and efficient candidates for clinical applications.</div></div>","PeriodicalId":342,"journal":{"name":"iScience","volume":"29 1","pages":"Article 114329"},"PeriodicalIF":4.1,"publicationDate":"2025-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145788922","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-03DOI: 10.1016/j.isci.2025.114324
Lisa Marie Stach , Lisa Gerarda Maria Huis in ‘t Veld , Theres Schaub , Marina Jendrach , Marta Ornaghi , Marius Schwabenland , Antje Beling , Sandra Pinkert
This study presents an in vivo model of coxsackievirus B3 infection in the brain to examine interferon (IFN) responses and effects on tissue-resident immune cells. Primary cell culture studies revealed that neurons exhibited substantial viral replication with a limited IFN response, whereas microglia, which showed no viral replication, displayed strong immune activation. In vivo analysis captured IFN responses and immune cell dynamics across both acute and chronic inflammation phases. During the acute stage, IFN responses intensified in a dose-dependent manner, with upregulated IFN-stimulated genes (ISGs), increased ISGylation, and microglial activation. Chemokine release coincided with the infiltration of monocytes and T cells in the injured brain. In the chronic phase, viral RNA was undetectable, yet flow cytometry showed persistent T cell presence and low-level microglial activation, indicating ongoing inflammation. This model provides a valuable platform for investigating IFN responses and immune cell interactions in central nervous system (CNS) viral infections and neuroinflammatory conditions.
{"title":"Decoding IFN-mediated immunity and cell dynamics in viral encephalitis: Insights from coxsackievirus B3 infection","authors":"Lisa Marie Stach , Lisa Gerarda Maria Huis in ‘t Veld , Theres Schaub , Marina Jendrach , Marta Ornaghi , Marius Schwabenland , Antje Beling , Sandra Pinkert","doi":"10.1016/j.isci.2025.114324","DOIUrl":"10.1016/j.isci.2025.114324","url":null,"abstract":"<div><div>This study presents an <em>in vivo</em> model of coxsackievirus B3 infection in the brain to examine interferon (IFN) responses and effects on tissue-resident immune cells. Primary cell culture studies revealed that neurons exhibited substantial viral replication with a limited IFN response, whereas microglia, which showed no viral replication, displayed strong immune activation. <em>In vivo</em> analysis captured IFN responses and immune cell dynamics across both acute and chronic inflammation phases. During the acute stage, IFN responses intensified in a dose-dependent manner, with upregulated IFN-stimulated genes (ISGs), increased ISGylation, and microglial activation. Chemokine release coincided with the infiltration of monocytes and T cells in the injured brain. In the chronic phase, viral RNA was undetectable, yet flow cytometry showed persistent T cell presence and low-level microglial activation, indicating ongoing inflammation. This model provides a valuable platform for investigating IFN responses and immune cell interactions in central nervous system (CNS) viral infections and neuroinflammatory conditions.</div></div>","PeriodicalId":342,"journal":{"name":"iScience","volume":"29 1","pages":"Article 114324"},"PeriodicalIF":4.1,"publicationDate":"2025-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145788758","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-03DOI: 10.1016/j.isci.2025.114323
Wenyu Guo , Yihao Yang , Ying Liang , Fei Cui , Lianzhong Li , Xuechun Peng , Jing Zhou , Ya Li , Yuezhi Deng , Yixuan Wang , Rong Chen , Tao Wen , Cheng Lin , Weihong Lin , Lidong Liu , Yongping Lin , Qigao Chen
Human adenovirus type 14p1 (HAdV-14p1) is associated with severe respiratory illness. Using human airway organoids, we characterized the cellular tropism, infection dynamics, and cellular response to HAdV-14p1, and evaluated the antiviral efficacy of cidofovir. HAdV-14p1 robustly infected and replicated in human airway organoids, particularly targeting ciliated, basal, and goblet cells. CCL5, CXCL10, CXCL11, and TNFSF13B were significantly upregulated upon HAdV-14p1 infection, indicating inflammatory activation. Pathway enrichment analysis revealed that upregulated genes were enriched in p53 signaling, cytokine-cytokine receptor interaction, and NOD-like receptor signaling pathways, whereas downregulated genes were linked to focal adhesion, tight junction, metabolic pathways, and oxidative phosphorylation pathways. Furthermore, treatment with cidofovir effectively inhibited viral replication with low cytotoxicity. Our findings highlight the robust replication and proinflammatory response that shape HAdV-14p1 pathogenesis and underscore the value of organoid systems in probing virus-host interactions and evaluating candidate antiviral strategies.
{"title":"Tropism, replication competence, and cellular responses of HAdV-14p1 in human airway organoids","authors":"Wenyu Guo , Yihao Yang , Ying Liang , Fei Cui , Lianzhong Li , Xuechun Peng , Jing Zhou , Ya Li , Yuezhi Deng , Yixuan Wang , Rong Chen , Tao Wen , Cheng Lin , Weihong Lin , Lidong Liu , Yongping Lin , Qigao Chen","doi":"10.1016/j.isci.2025.114323","DOIUrl":"10.1016/j.isci.2025.114323","url":null,"abstract":"<div><div>Human adenovirus type 14p1 (HAdV-14p1) is associated with severe respiratory illness. Using human airway organoids, we characterized the cellular tropism, infection dynamics, and cellular response to HAdV-14p1, and evaluated the antiviral efficacy of cidofovir. HAdV-14p1 robustly infected and replicated in human airway organoids, particularly targeting ciliated, basal, and goblet cells. CCL5, CXCL10, CXCL11, and TNFSF13B were significantly upregulated upon HAdV-14p1 infection, indicating inflammatory activation. Pathway enrichment analysis revealed that upregulated genes were enriched in p53 signaling, cytokine-cytokine receptor interaction, and NOD-like receptor signaling pathways, whereas downregulated genes were linked to focal adhesion, tight junction, metabolic pathways, and oxidative phosphorylation pathways. Furthermore, treatment with cidofovir effectively inhibited viral replication with low cytotoxicity. Our findings highlight the robust replication and proinflammatory response that shape HAdV-14p1 pathogenesis and underscore the value of organoid systems in probing virus-host interactions and evaluating candidate antiviral strategies.</div></div>","PeriodicalId":342,"journal":{"name":"iScience","volume":"29 1","pages":"Article 114323"},"PeriodicalIF":4.1,"publicationDate":"2025-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145788916","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-03DOI: 10.1016/j.isci.2025.114325
Mohamed Saad , Stijn N.R. Fuchs , Carmen Schalla , Katrin Götz , Jessica E. Pritchard , Niclas Flosdorf , Adam Benabid , Hélène F.E. Gleitz , Nils Leimkühler , Aurélien Dugourd , Rebekka K. Schneider
Myeloproliferative neoplasms (MPNs), particularly with myelofibrosis (MF), involve a disrupted perivascular hematopoietic niche, ultimately leading to bone marrow fibrosis. We asked if the transcriptome in cell-free RNA (cf-RNA) from the peripheral blood of patients with MPN (with JAK2V617F mutation) can detect bone marrow fibrosis. Transcriptomic profiling revealed significant gene expression changes correlating with reticulin fibrosis grades. Advanced reticulin fibrosis grades (2–3) showed upregulation of TGF-β pathways and extracellular matrix (ECM) remodeling markers, with decreased hematopoietic support. Grade 3 fibrosis was associated with increased proliferation signals and elevated inflammatory markers (S100A8/9). RUNX1 was identified as a key transcription factor in fibrosis, with its overexpression driving myofibroblast differentiation in mesenchymal stromal cells. IL-18 emerged as a critical inflammatory mediator, with elevated plasma levels correlating with the transformation to high-grade fibrosis (reticulin grades 2–3). Functional assays confirmed that the IL-18 stimulation of mesenchymal stromal cells induced fibrotic transformation, emphasizing its role as a biomarker and target.
{"title":"Non-invasive detection of bone marrow fibrosis in myeloproliferative neoplasms using cell-free RNA","authors":"Mohamed Saad , Stijn N.R. Fuchs , Carmen Schalla , Katrin Götz , Jessica E. Pritchard , Niclas Flosdorf , Adam Benabid , Hélène F.E. Gleitz , Nils Leimkühler , Aurélien Dugourd , Rebekka K. Schneider","doi":"10.1016/j.isci.2025.114325","DOIUrl":"10.1016/j.isci.2025.114325","url":null,"abstract":"<div><div>Myeloproliferative neoplasms (MPNs), particularly with myelofibrosis (MF), involve a disrupted perivascular hematopoietic niche, ultimately leading to bone marrow fibrosis. We asked if the transcriptome in cell-free RNA (cf-RNA) from the peripheral blood of patients with MPN (with JAK2V617F mutation) can detect bone marrow fibrosis. Transcriptomic profiling revealed significant gene expression changes correlating with reticulin fibrosis grades. Advanced reticulin fibrosis grades (2–3) showed upregulation of TGF-β pathways and extracellular matrix (ECM) remodeling markers, with decreased hematopoietic support. Grade 3 fibrosis was associated with increased proliferation signals and elevated inflammatory markers (S100A8/9). RUNX1 was identified as a key transcription factor in fibrosis, with its overexpression driving myofibroblast differentiation in mesenchymal stromal cells. IL-18 emerged as a critical inflammatory mediator, with elevated plasma levels correlating with the transformation to high-grade fibrosis (reticulin grades 2–3). Functional assays confirmed that the IL-18 stimulation of mesenchymal stromal cells induced fibrotic transformation, emphasizing its role as a biomarker and target.</div></div>","PeriodicalId":342,"journal":{"name":"iScience","volume":"29 1","pages":"Article 114325"},"PeriodicalIF":4.1,"publicationDate":"2025-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145788913","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-03DOI: 10.1016/j.isci.2025.114320
Qiang Li , Ge Zhang , Honglin Zheng , Taiqi Zhao , Hang Zhang , Yaochong Zhang , Haiyang Luo , Yuming Xu
Amyotrophic lateral sclerosis (ALS) is a progressive motor neuron disease lacking reliable biomarkers and effective therapeutic targets. We performed an integrative multiscale analysis combining global epidemiology, whole-blood transcriptomics, machine learning, and Mendelian randomization (MR). We developed a nine-gene diagnostic signature (AUC = 0.75 in external validation) and identified ATP-binding cassette transporter A1 (ABCA1) as a central feature. MR analyses supported a protective causal relationship between increased ABCA1 expression and reduced ALS risk (OR = 0.93, p = 0.02). We validated this at the protein level, finding serum ABCA1 significantly elevated in an in-house ALS cohort (p = 0.006) and correlated with metabolic parameters (BMI and LDL). Spatiotemporal profiling confirmed ABCA1 upregulation in ALS patient blood and spinal cords, and progressive upregulation in ALS model mice. Collectively, we validated a diagnostic signature and identified ABCA1 as a protective, compensatory biomarker in ALS, emphasizing the link between metabolic adaptation and neurodegeneration.
{"title":"ABCA1 acts as a protective modulator in amyotrophic lateral sclerosis","authors":"Qiang Li , Ge Zhang , Honglin Zheng , Taiqi Zhao , Hang Zhang , Yaochong Zhang , Haiyang Luo , Yuming Xu","doi":"10.1016/j.isci.2025.114320","DOIUrl":"10.1016/j.isci.2025.114320","url":null,"abstract":"<div><div>Amyotrophic lateral sclerosis (ALS) is a progressive motor neuron disease lacking reliable biomarkers and effective therapeutic targets. We performed an integrative multiscale analysis combining global epidemiology, whole-blood transcriptomics, machine learning, and Mendelian randomization (MR). We developed a nine-gene diagnostic signature (AUC = 0.75 in external validation) and identified ATP-binding cassette transporter A1 (<em>ABCA1</em>) as a central feature. MR analyses supported a protective causal relationship between increased ABCA1 expression and reduced ALS risk (OR = 0.93, <em>p</em> = 0.02). We validated this at the protein level, finding serum ABCA1 significantly elevated in an in-house ALS cohort (<em>p</em> = 0.006) and correlated with metabolic parameters (BMI and LDL). Spatiotemporal profiling confirmed ABCA1 upregulation in ALS patient blood and spinal cords, and progressive upregulation in ALS model mice. Collectively, we validated a diagnostic signature and identified ABCA1 as a protective, compensatory biomarker in ALS, emphasizing the link between metabolic adaptation and neurodegeneration.</div></div>","PeriodicalId":342,"journal":{"name":"iScience","volume":"29 1","pages":"Article 114320"},"PeriodicalIF":4.1,"publicationDate":"2025-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145788764","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-12-03DOI: 10.1016/j.isci.2025.114327
Shiyuan Zhang , Mengyuan Li , Bin Xu , Xiaojian Zhu , Xia Mao , Hao Zhou , Xiwen Tong , Shuai Su , Yi Zhu , Donghua Zhang
Decitabine has demonstrated efficacy in the treatment of acute myeloid leukemia (AML), though therapeutic responses vary widely due to the disease’s inherent heterogeneity. To address this clinical challenge, we aimed to identify reliable biomarkers for predicting decitabine responsiveness in patients with AML. In our previous studies, integrated epigenetic and transcriptomic profiling identified BTG1 as a methylation-associated tumor suppressor gene correlated with decitabine sensitivity. We found that decitabine upregulates BTG1 expression through demethylation, and this upregulation enhances the sensitivity of AML cells to decitabine. BTG1 may exert its effect through the Wnt/β-catenin signaling pathway. Notably, BTG1 expression levels were significantly associated with treatment outcomes, including complete remission (CR) rates and measurable residual disease (MRD) negativity in patients receiving decitabine-containing regimens (either “7 + 3” or alternative combinations). Importantly, peripheral blood BTG1 mRNA expression levels reliably predicted therapeutic response to decitabine, establishing BTG1 as a robust biomarker of decitabine efficacy in AML management.
{"title":"Prognostic value of BTG1 for predicting decitabine sensitivity in de novo acute myeloid leukemia","authors":"Shiyuan Zhang , Mengyuan Li , Bin Xu , Xiaojian Zhu , Xia Mao , Hao Zhou , Xiwen Tong , Shuai Su , Yi Zhu , Donghua Zhang","doi":"10.1016/j.isci.2025.114327","DOIUrl":"10.1016/j.isci.2025.114327","url":null,"abstract":"<div><div>Decitabine has demonstrated efficacy in the treatment of acute myeloid leukemia (AML), though therapeutic responses vary widely due to the disease’s inherent heterogeneity. To address this clinical challenge, we aimed to identify reliable biomarkers for predicting decitabine responsiveness in patients with AML. In our previous studies, integrated epigenetic and transcriptomic profiling identified BTG1 as a methylation-associated tumor suppressor gene correlated with decitabine sensitivity. We found that decitabine upregulates BTG1 expression through demethylation, and this upregulation enhances the sensitivity of AML cells to decitabine. BTG1 may exert its effect through the Wnt/β-catenin signaling pathway. Notably, BTG1 expression levels were significantly associated with treatment outcomes, including complete remission (CR) rates and measurable residual disease (MRD) negativity in patients receiving decitabine-containing regimens (either “7 + 3” or alternative combinations). Importantly, peripheral blood BTG1 mRNA expression levels reliably predicted therapeutic response to decitabine, establishing BTG1 as a robust biomarker of decitabine efficacy in AML management.</div><div>Clinical trial registration: ChiCTR2000037928.</div></div>","PeriodicalId":342,"journal":{"name":"iScience","volume":"29 1","pages":"Article 114327"},"PeriodicalIF":4.1,"publicationDate":"2025-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145788754","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
In this retrospective study of 251 pediatric patients with T cell acute lymphoblastic leukemia (T-ALL), chronic hepatitis B virus (HBV) infection with acute exacerbation (CHB-AE) was associated with significantly poorer outcomes. Compared to patients with HBV-negative, the CHB-AE cohort had markedly inferior 5-year event-free survival (13.24% vs. 80.58%) and overall survival. After using propensity score matching to balance baseline characteristics, the difference in event-free survival remained significant. Subgroup analyses consistently showed worse outcomes for patients with CHB-AE, particularly those with high-risk features such as elevated leukocyte counts or central nervous system involvement. The study identifies HBV coinfection as an independent adverse prognostic factor in pediatric T-ALL. These findings highlight the urgent need for prospective studies to investigate the underlying mechanisms and to develop novel therapeutic strategies for this high-risk patient subgroup.
{"title":"Chronic hepatitis b coinfection and survival in pediatric T-ALL: A propensity-matched analysis","authors":"Yutong Zhang , Ruihong Wu , Yuan Zhang , Yufei Zhao , Xiaodan Zhong , Xianmei Jin , Chao Zhang , Jian Chang","doi":"10.1016/j.isci.2025.114319","DOIUrl":"10.1016/j.isci.2025.114319","url":null,"abstract":"<div><div>In this retrospective study of 251 pediatric patients with T cell acute lymphoblastic leukemia (T-ALL), chronic hepatitis B virus (HBV) infection with acute exacerbation (CHB-AE) was associated with significantly poorer outcomes. Compared to patients with HBV-negative, the CHB-AE cohort had markedly inferior 5-year event-free survival (13.24% vs. 80.58%) and overall survival. After using propensity score matching to balance baseline characteristics, the difference in event-free survival remained significant. Subgroup analyses consistently showed worse outcomes for patients with CHB-AE, particularly those with high-risk features such as elevated leukocyte counts or central nervous system involvement. The study identifies HBV coinfection as an independent adverse prognostic factor in pediatric T-ALL. These findings highlight the urgent need for prospective studies to investigate the underlying mechanisms and to develop novel therapeutic strategies for this high-risk patient subgroup.</div></div>","PeriodicalId":342,"journal":{"name":"iScience","volume":"29 1","pages":"Article 114319"},"PeriodicalIF":4.1,"publicationDate":"2025-12-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145788829","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}